Use of monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues

R. M. Denney, R. R. Fritz, N. T. Patel, Steven Widen, C. W. Abell

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Monoamine oxidase B (MAO B; EC 1.4.3.4) activity in detergent extracts of mitochondria for autopsy brain (gray matter and medulla) liver, lung, and kidney from a single individual and from pooled, human platelets could be immunoprecipitated by a monoclonal anti-human platelet MAO B antibody (MAO-1C2) in combination with appropriate secondary reagents. MAO A activity, which was detected in brain, liver, lung, and kidney, was not immunoprecipitated under the same conditions. All MAO B-containing extracts, regardless of tissue source, inhibited immunoprecipitation of [3H]pargyline-labeled human platelet MAO, and the shapes of the inhibition curves were identical. The concentration of immunologically detectable MAO B protein in the extracts was estimated from immunoprecipitation competition data by reference to a standard curve relating observed inhibition of immunoprecipitation to the concentration of catalytically active platelet MAO added (estimated from [3H]pargyline binding data). MAO B protein concentrations measured by this radioimmunoassay were similar to concentrations of active MAO B as measured by pargyline binding. These results demonstrate that in the brain and peripheral tissues studied, molecules with MAO B activity share a unique antigenic determinant and similar catalytic efficiency. They also extend previous observations that MAO B molecules extracted from mitochondria bear an antigenic determinant which is not present on MAO A molecules. These results demonstrate the validity of new competitive radioimmunoassay for active plus inactive MAO B concentration in human platelet extracts and extracts of mitochondria from tissues. This radioimmunoassay should complement [3H]pargyline binding assays and enzyme assays in studies designed to clarify the mechanisms of genetic, disease, and treatment factors which lead to differences in MAO B function among individuals.

Original languageEnglish (US)
Pages (from-to)60-68
Number of pages9
JournalMolecular Pharmacology
Volume24
Issue number1
StatePublished - Sep 8 1983
Externally publishedYes

Fingerprint

Monoamine Oxidase
Monoclonal Antibodies
Brain
Pargyline
Blood Platelets
Immunoprecipitation
Radioimmunoassay
Mitochondria
Tissue Extracts
Epitopes
Kidney
Lung
Inborn Genetic Diseases
Liver
Enzyme Assays
Reproducibility of Results
Detergents

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Use of monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues. / Denney, R. M.; Fritz, R. R.; Patel, N. T.; Widen, Steven; Abell, C. W.

In: Molecular Pharmacology, Vol. 24, No. 1, 08.09.1983, p. 60-68.

Research output: Contribution to journalArticle

@article{c0f3e40e297e4a7ab5a073d2ff44965c,
title = "Use of monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues",
abstract = "Monoamine oxidase B (MAO B; EC 1.4.3.4) activity in detergent extracts of mitochondria for autopsy brain (gray matter and medulla) liver, lung, and kidney from a single individual and from pooled, human platelets could be immunoprecipitated by a monoclonal anti-human platelet MAO B antibody (MAO-1C2) in combination with appropriate secondary reagents. MAO A activity, which was detected in brain, liver, lung, and kidney, was not immunoprecipitated under the same conditions. All MAO B-containing extracts, regardless of tissue source, inhibited immunoprecipitation of [3H]pargyline-labeled human platelet MAO, and the shapes of the inhibition curves were identical. The concentration of immunologically detectable MAO B protein in the extracts was estimated from immunoprecipitation competition data by reference to a standard curve relating observed inhibition of immunoprecipitation to the concentration of catalytically active platelet MAO added (estimated from [3H]pargyline binding data). MAO B protein concentrations measured by this radioimmunoassay were similar to concentrations of active MAO B as measured by pargyline binding. These results demonstrate that in the brain and peripheral tissues studied, molecules with MAO B activity share a unique antigenic determinant and similar catalytic efficiency. They also extend previous observations that MAO B molecules extracted from mitochondria bear an antigenic determinant which is not present on MAO A molecules. These results demonstrate the validity of new competitive radioimmunoassay for active plus inactive MAO B concentration in human platelet extracts and extracts of mitochondria from tissues. This radioimmunoassay should complement [3H]pargyline binding assays and enzyme assays in studies designed to clarify the mechanisms of genetic, disease, and treatment factors which lead to differences in MAO B function among individuals.",
author = "Denney, {R. M.} and Fritz, {R. R.} and Patel, {N. T.} and Steven Widen and Abell, {C. W.}",
year = "1983",
month = "9",
day = "8",
language = "English (US)",
volume = "24",
pages = "60--68",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Use of monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues

AU - Denney, R. M.

AU - Fritz, R. R.

AU - Patel, N. T.

AU - Widen, Steven

AU - Abell, C. W.

PY - 1983/9/8

Y1 - 1983/9/8

N2 - Monoamine oxidase B (MAO B; EC 1.4.3.4) activity in detergent extracts of mitochondria for autopsy brain (gray matter and medulla) liver, lung, and kidney from a single individual and from pooled, human platelets could be immunoprecipitated by a monoclonal anti-human platelet MAO B antibody (MAO-1C2) in combination with appropriate secondary reagents. MAO A activity, which was detected in brain, liver, lung, and kidney, was not immunoprecipitated under the same conditions. All MAO B-containing extracts, regardless of tissue source, inhibited immunoprecipitation of [3H]pargyline-labeled human platelet MAO, and the shapes of the inhibition curves were identical. The concentration of immunologically detectable MAO B protein in the extracts was estimated from immunoprecipitation competition data by reference to a standard curve relating observed inhibition of immunoprecipitation to the concentration of catalytically active platelet MAO added (estimated from [3H]pargyline binding data). MAO B protein concentrations measured by this radioimmunoassay were similar to concentrations of active MAO B as measured by pargyline binding. These results demonstrate that in the brain and peripheral tissues studied, molecules with MAO B activity share a unique antigenic determinant and similar catalytic efficiency. They also extend previous observations that MAO B molecules extracted from mitochondria bear an antigenic determinant which is not present on MAO A molecules. These results demonstrate the validity of new competitive radioimmunoassay for active plus inactive MAO B concentration in human platelet extracts and extracts of mitochondria from tissues. This radioimmunoassay should complement [3H]pargyline binding assays and enzyme assays in studies designed to clarify the mechanisms of genetic, disease, and treatment factors which lead to differences in MAO B function among individuals.

AB - Monoamine oxidase B (MAO B; EC 1.4.3.4) activity in detergent extracts of mitochondria for autopsy brain (gray matter and medulla) liver, lung, and kidney from a single individual and from pooled, human platelets could be immunoprecipitated by a monoclonal anti-human platelet MAO B antibody (MAO-1C2) in combination with appropriate secondary reagents. MAO A activity, which was detected in brain, liver, lung, and kidney, was not immunoprecipitated under the same conditions. All MAO B-containing extracts, regardless of tissue source, inhibited immunoprecipitation of [3H]pargyline-labeled human platelet MAO, and the shapes of the inhibition curves were identical. The concentration of immunologically detectable MAO B protein in the extracts was estimated from immunoprecipitation competition data by reference to a standard curve relating observed inhibition of immunoprecipitation to the concentration of catalytically active platelet MAO added (estimated from [3H]pargyline binding data). MAO B protein concentrations measured by this radioimmunoassay were similar to concentrations of active MAO B as measured by pargyline binding. These results demonstrate that in the brain and peripheral tissues studied, molecules with MAO B activity share a unique antigenic determinant and similar catalytic efficiency. They also extend previous observations that MAO B molecules extracted from mitochondria bear an antigenic determinant which is not present on MAO A molecules. These results demonstrate the validity of new competitive radioimmunoassay for active plus inactive MAO B concentration in human platelet extracts and extracts of mitochondria from tissues. This radioimmunoassay should complement [3H]pargyline binding assays and enzyme assays in studies designed to clarify the mechanisms of genetic, disease, and treatment factors which lead to differences in MAO B function among individuals.

UR - http://www.scopus.com/inward/record.url?scp=0020535717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020535717&partnerID=8YFLogxK

M3 - Article

C2 - 6191193

AN - SCOPUS:0020535717

VL - 24

SP - 60

EP - 68

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 1

ER -